Primecap Management Co. CA trimmed its position in shares of IMAX Corporation (NYSE:IMAX – Free Report) by 15.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 635,502 shares of the company’s stock after selling 116,100 shares during the quarter. Primecap Management Co. CA owned 1.18% of IMAX worth $20,813,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the business. TD Waterhouse Canada Inc. increased its stake in IMAX by 125.0% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 900 shares of the company’s stock valued at $25,000 after purchasing an additional 500 shares in the last quarter. First Horizon Corp acquired a new position in shares of IMAX during the third quarter valued at about $34,000. Jones Financial Companies Lllp increased its position in shares of IMAX by 43.8% during the third quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company’s stock worth $34,000 after acquiring an additional 317 shares in the last quarter. Clearstead Advisors LLC bought a new stake in shares of IMAX during the third quarter worth about $35,000. Finally, Farther Finance Advisors LLC raised its holdings in shares of IMAX by 467.8% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,215 shares of the company’s stock worth $40,000 after acquiring an additional 1,001 shares during the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.
IMAX Stock Up 2.6%
Shares of IMAX stock opened at $42.86 on Friday. The firm has a market cap of $2.31 billion, a P/E ratio of 69.13, a PEG ratio of 2.07 and a beta of 0.38. The company has a 50 day moving average of $36.44 and a 200-day moving average of $33.99. IMAX Corporation has a 12-month low of $20.48 and a 12-month high of $43.16.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Barrington Research reissued an “outperform” rating and set a $42.00 price objective on shares of IMAX in a report on Monday, January 26th. Macquarie Infrastructure lifted their target price on IMAX from $39.00 to $44.00 and gave the company an “outperform” rating in a research report on Thursday, January 15th. Wall Street Zen lowered IMAX from a “strong-buy” rating to a “buy” rating in a research report on Saturday. B. Riley Financial reaffirmed a “buy” rating on shares of IMAX in a report on Monday, December 8th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of IMAX in a research note on Monday, December 29th. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, IMAX currently has an average rating of “Moderate Buy” and an average target price of $43.00.
View Our Latest Analysis on IMAX
Key IMAX News
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Q4 earnings beat and strong growth — IMAX reported $0.58 EPS vs. $0.43 consensus and revenue of $125.2M (up ~35% y/y), driven by blockbuster titles and higher profitability. This is the primary catalyst for the stock move. Earnings Report
- Positive Sentiment: Analyst upgrades — JPMorgan raised its price target to $48 and kept an “overweight” rating, signaling meaningful upside; Benchmark also raised its target to $44 and reiterated a “buy”. Analyst bullishness supports further upside sentiment. Analyst Note Benchmark Note
- Positive Sentiment: Strong box-office backdrop and targets — Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach, suggesting recurring upside if tentpoles and slate perform. Box Office Target
- Positive Sentiment: Content wins and programming diversification — Dune 3 secured exclusive IMAX opening-weekend play in select markets (good for premium ticket sales), Studio Ghibli re-releases and live F1 broadcasts broaden non-traditional revenue streams. Dune 3 Article Ghibli Re-release F1 in IMAX
- Neutral Sentiment: Institutional support — Rosenblatt reiterated a buy and other boutiques remain constructive; this helps sentiment but is not new fundamental strength. Rosenblatt Note
- Neutral Sentiment: Investor materials available — The earnings call transcript and slide deck were published for deeper inspection; useful for gauging guidance and margin drivers but not an immediate price catalyst. Earnings Call Transcript
- Negative Sentiment: Opening-weekend windowing risk — Major title Avengers: Doomsday will not have an IMAX opening-weekend release in the U.S., which could blunt upside from that particular tentpole and offset some gains from other exclusives. Avengers Windowing
IMAX Company Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Recommended Stories
- Five stocks we like better than IMAX
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
